Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have been assigned a consensus rating of “Hold” from the six ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $45.50.
TRUP has been the subject of several research analyst reports. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Piper Sandler cut their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Cantor Fitzgerald decreased their price objective on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a report on Wednesday, January 14th. Stifel Nicolaus lowered their price objective on shares of Trupanion from $38.00 to $35.00 and set a “hold” rating for the company in a research report on Friday, February 13th. Finally, Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th.
Read Our Latest Analysis on TRUP
Trupanion Trading Down 3.5%
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The business had revenue of $376.85 million for the quarter, compared to the consensus estimate of $375.89 million. Trupanion’s revenue was up 11.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.04 earnings per share. On average, equities analysts forecast that Trupanion will post 0.13 EPS for the current year.
Insider Transactions at Trupanion
In other Trupanion news, CFO Fawwad Qureshi sold 4,645 shares of the company’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $25.61, for a total value of $118,958.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Margaret Tooth sold 9,605 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $37.88, for a total value of $363,837.40. Following the transaction, the chief executive officer directly owned 150,294 shares in the company, valued at $5,693,136.72. The trade was a 6.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 31,107 shares of company stock worth $949,347 in the last ninety days. 5.42% of the stock is owned by company insiders.
Institutional Trading of Trupanion
A number of hedge funds have recently added to or reduced their stakes in the business. Federated Hermes Inc. purchased a new position in Trupanion during the 3rd quarter valued at about $33,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Trupanion in the 3rd quarter worth approximately $39,000. Kelleher Financial Advisors bought a new position in shares of Trupanion during the third quarter valued at approximately $74,000. Kemnay Advisory Services Inc. purchased a new position in Trupanion during the fourth quarter valued at approximately $64,000. Finally, PNC Financial Services Group Inc. increased its holdings in Trupanion by 21.7% during the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after buying an additional 478 shares during the period.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Articles
- Five stocks we like better than Trupanion
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
